Lymphoma Rounds: Seattle
NEW LOCATION! – Crowne Plaza Seattle Downtown (click here for directions)
1113 6th Avenue
Seattle, WA 98101
Wednesday, February 27, 2019
6:00 PM – 8:30 PM
ACTIVITY CHAIR
John M. Pagel, MD, PhD, DSc
Swedish Cancer Institute
Seattle, Washington
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.
Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, pharmon@lymphoma.org. Exhibit opportunities are also available, however, space is limited.
Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon (pharmon@lymphoma.org) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.
PROGRAM AGENDA
| 6:00 PM | Registration and Dinner Buffet |
|---|---|
| 6:45 PM | Welcome |
| Piper Harmon, Lymphoma Research Foundation | |
| John Pagel, MD, PhD, DSc, Swedish Medical Center | |
| Pathology for all cases will be presented by David Li, MD, University of Washington | |
| 7:00 PM | The Baking Sign: A New Prognostic Tool for Aggressive Lymphoma |
| Ami Batchelder, PA-C, Swedish Medical Center | |
| Moderator | |
| John Pagel, MD, PhD, DSc, Swedish Medical Center | |
| 7:30 PM | What to Do When Salvage Chemotherapy for DLBCL Fails: 2019 Edition |
| Erik Kimble, MD, Seattle Cancer Care Alliance |
|
| Moderator | |
| Ryan Lynch, MD, Seattle Cancer Care Alliance |
|
| 8:00 PM | When CAR T-cell Therapy Fails |
| Victor Chow, MD, University of Washington/Fred Hutchinson Cancer Research Center | |
| Moderator | |
| Stephen Smith, MD, Seattle Cancer Care Alliance | |
| 8:30 PM | Adjourn |
ABOUT THE PROGRAM
The Lymphoma Research Foundation’s Seattle Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Seattle area.
At the conclusion of this educational activity, the participant should be better able to:
- Summarize the latest developments in lymphoma diagnosis, treatment and management.
- Apply best practices for treating lymphoma patients.
- Inform patients about potential clinical trial opportunities.
- Establish a network of health care professionals who work with lymphoma patients.
- Wednesday, May 1, 2019
Seattle Lymphoma Rounds Steering Committee
Kaiser Permanente Washington
Eric Chen, MD, PhD
The Polyclinic
Sherry Hu, MD, PhD
Swedish Medical Center
Hank Kaplan, MD
John Pagel, MD, PhD, DSc (chair)
University of Washington
Paul S. Martin, MD
University of Washington/Fred Hutchinson Cancer Research Center
Stephen D. Smith, MD
Virginia Mason Medical Center
David Aboulafia, MD
Joint Providership Statement
This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.
Accreditation Statement
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Statement
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsors
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education
This activity is supported by educational grants from:
AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology
